Association study of ADORA2A gene polymorphisms with adverse drug reactions to valproic acid and oxcarbazepine in the treatment of children with epilepsy
Epilepsia · 2025
DOI: 10.1111/epi.18587 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsia, 2025. Verfasst von Xixuan Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Shenzhen Baoan Women's and Children's Hospital, Jinan University, Shenzhen, China. Hauptthemen laut MEDLINE: Oxcarbazepine, Epilepsy, Anticonvulsants, Receptor, Adenosine A2A. Die Arbeit nennt 50 Literaturangaben. Gefördert von: Talent Project of Hospital Pharmacy Committee of the Chinese Pharmaceutical Association, Wellcome Trust, Shenzhen Baoan medical health research project.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Objective
Adenosine, a purine nucleotide, is implicated in various brain disorders. Our previous study identified a correlation between ADORA2A variants and epilepsy susceptibility. However, it remains unclear whether ADORA2A genetic polymorphisms affect the outcomes of antiseizure medication (ASM) therapy. This study aimed to investigate the association between ADORA2A gene polymorphisms and the efficacy and adverse drug reactions (ADRs) of ASM.
Methods
In this study, 278 children with epilepsy treated with ASM were retrospectively recruited. Among them, 208 children received valproic acid (VPA), 113 received oxcarbazepine (OXC), and 43 received a combination of VPA and OXC. The ADORA2A rs2298383 polymorphism was genotyped using the Sequenom MassArray system. Additionally, putative targets and pathways associated with ADORA2A in ADRs induced by ASM were identified through protein–protein interaction, Kyoto Encyclopedia of Genes and Genomes, and Gene Ontology functional enrichment analysis.
Results
The ADORA2A rs2298383 polymorphism was not significantly associated with drug responsiveness in children with epilepsy. However, the rs2298383 TT genotype was potentially protective against VPA‐induced weight gain ( p = .006) but may have increased the likelihood of OXC‐induced cutaneous ADRs ( p = .030). Furthermore, bioinformatic analysis revealed that nine target genes associated with VPA‐induced weight gain were primarily involved in the “positive regulation of mitogen‐activated protein kinase cascade,” “calcium signaling pathway,” and “cyclic adenosine monophosphate signaling pathway” pathways/processes. Significance This study demonstrates that ADORA2A gene polymorphisms can assist in predicting the impact of ASM on outcomes in children with epilepsy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Shenzhen Baoan Women's and Children's Hospital, Jinan University, Shenzhen, China.
- Department of Clinical Pharmacology, College of Pharmacy, Jinan University, Guangzhou, China.
- Department of Pharmacy, Shenzhen Qianhai Shekou Free Trade Zone Hospital, Shenzhen, China.
ORCID-Profile: Xixuan Wang, Jiahao Zhu, Xi Li, Hanbing Xia, Jieluan Lu, Yaodong He, Xianhuan Shen, Jianping Zhang, Xiaomei Fan, Wenzhou Li
Förderung
- Talent Project of Hospital Pharmacy Committee of the Chinese Pharmaceutical Association
- Wellcome Trust
- Shenzhen Baoan medical health research project
- Natural Science Foundation of Guangdong province
- Shenzhen Science and Technology Planning Program
- Research Foundation of Shenzhen Baoan Women's and Children's Hospital
Zitieren
APA
Wang, X., Zhu, J., Li, X., Xia, H., Lu, J., He, Y., Shen, X., Zhang, J., Fan, X., & Li, W. (2025). Association study of ADORA2A gene polymorphisms with adverse drug reactions to valproic acid and oxcarbazepine in the treatment of children with epilepsy. Epilepsia. https://doi.org/10.1111/epi.18587
Vancouver
Wang X, Zhu J, Li X, Xia H, Lu J, He Y, et al. Association study of ADORA2A gene polymorphisms with adverse drug reactions to valproic acid and oxcarbazepine in the treatment of children with epilepsy. Epilepsia. 2025. doi:10.1111/epi.18587
BibTeX
@article{Wang2025,
author = {Wang, Xixuan and Zhu, Jiahao and Li, Xi and Xia, Hanbing and Lu, Jieluan and He, Yaodong and Shen, Xianhuan and Zhang, Jianping and Fan, Xiaomei and Li, Wenzhou},
title = {Association study of ADORA2A gene polymorphisms with adverse drug reactions to valproic acid and oxcarbazepine in the treatment of children with epilepsy},
journal = {Epilepsia},
year = {2025},
doi = {10.1111/epi.18587}
}
EUVIMED